XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Adjustment to opening retained earnings due to adoption of ASU 2020-06
Class A voting common stock
Class B voting common stock
Common stock
Class A voting common stock
Common stock
Class B voting common stock
Additional paid-in capital
Additional paid-in capital
Adjustment to opening retained earnings due to adoption of ASU 2020-06
Accumulated other comprehensive income (loss)
Accumulated deficit
Accumulated deficit
Adjustment to opening retained earnings due to adoption of ASU 2020-06
Beginning balance (in shares) at Dec. 31, 2021         23,177,988 1,965,170          
Beginning balance at Dec. 31, 2021 $ 412,595 $ (147,498)     $ 23 $ 2 $ 502,477 $ (156,248) $ (13,040) $ (76,867) $ 8,750
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises of vested stock options (in shares)         16,095            
Exercises of vested stock options 125           125        
Vesting of restricted stock units (in shares)         144,977            
Equity awards withheld for tax liability (in shares)         (30,029)            
Equity awards withheld for tax liability (1,751)           (1,751)        
Foreign currency translation (10,516)               (10,516)    
Stock-based compensation 5,346           5,346        
Net loss (6,814)                 (6,814)  
Ending balance (in shares) at Mar. 31, 2022         23,309,031 1,965,170          
Ending balance at Mar. 31, 2022 251,487       $ 23 $ 2 349,949   (23,556) (74,931)  
Beginning balance (in shares) at Dec. 31, 2021         23,177,988 1,965,170          
Beginning balance at Dec. 31, 2021 412,595 $ (147,498)     $ 23 $ 2 502,477 $ (156,248) (13,040) (76,867) $ 8,750
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (13,864)                    
Ending balance (in shares) at Sep. 30, 2022         23,358,203 1,965,170          
Ending balance at Sep. 30, 2022 194,596       $ 23 $ 2 359,465   (82,913) (81,981)  
Beginning balance (in shares) at Mar. 31, 2022         23,309,031 1,965,170          
Beginning balance at Mar. 31, 2022 251,487       $ 23 $ 2 349,949   (23,556) (74,931)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises of vested stock options (in shares)         4,287            
Exercises of vested stock options 37           37        
Vesting of restricted stock units (in shares)         28,351            
Equity awards withheld for tax liability (in shares)         (7,005)            
Equity awards withheld for tax liability (145)           (145)        
Unrealized loss on marketable securities (338)               (338)    
Foreign currency translation (29,775)               (29,775)    
Stock-based compensation 4,821           4,821        
Net loss (6,248)                 (6,248)  
Ending balance (in shares) at Jun. 30, 2022         23,334,664 1,965,170          
Ending balance at Jun. 30, 2022 219,839       $ 23 $ 2 354,662   (53,669) (81,179)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Vesting of restricted stock units (in shares)         30,395            
Equity awards withheld for tax liability (in shares)         (6,856)            
Equity awards withheld for tax liability (89)           (89)        
Unrealized loss on marketable securities 458               458    
Foreign currency translation (29,702)               (29,702)    
Stock-based compensation 4,892           4,892        
Net loss (802)                 (802)  
Ending balance (in shares) at Sep. 30, 2022         23,358,203 1,965,170          
Ending balance at Sep. 30, 2022 194,596       $ 23 $ 2 359,465   (82,913) (81,981)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises of vested stock options (in shares)         86            
Exercises of vested stock options 1           1        
Vesting of restricted stock units (in shares)         27,511            
Equity awards withheld for tax liability (in shares)         (6,800)            
Equity awards withheld for tax liability (149)           (149)        
Unrealized loss on marketable securities 194               194    
Foreign currency translation 38,138               38,138    
Unrealized gain/loss on employee benefit pension plan 367               367    
Stock-based compensation 5,596           5,596        
Net loss 33,434                 33,434  
Ending balance (in shares) at Dec. 31, 2022     23,379,000 1,965,170 23,379,000 1,965,170          
Ending balance at Dec. 31, 2022 272,177       $ 23 $ 2 364,913   (44,214) (48,547)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises of vested stock options (in shares)         22,975            
Exercises of vested stock options 155           155        
Vesting of restricted stock units (in shares)         171,950            
Vesting of restricted stock units 1       $ 1            
Equity awards withheld for tax liability (in shares)         (43,325)            
Equity awards withheld for tax liability (903)           (903)        
Unrealized loss on marketable securities 72               72    
Foreign currency translation 7,647               7,647    
Stock-based compensation 6,649           6,649        
Net loss 3,611                 3,611  
Ending balance (in shares) at Mar. 31, 2023         23,530,600 1,965,170          
Ending balance at Mar. 31, 2023 289,409       $ 24 $ 2 370,814   (36,495) (44,936)  
Beginning balance (in shares) at Dec. 31, 2022     23,379,000 1,965,170 23,379,000 1,965,170          
Beginning balance at Dec. 31, 2022 $ 272,177       $ 23 $ 2 364,913   (44,214) (48,547)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises of vested stock options (in shares) 61,349                    
Net loss $ (5,409)                    
Ending balance (in shares) at Sep. 30, 2023     23,682,801 1,958,028 23,682,801 1,958,028          
Ending balance at Sep. 30, 2023 279,987       $ 24 $ 2 383,013   (49,096) (53,956)  
Beginning balance (in shares) at Mar. 31, 2023         23,530,600 1,965,170          
Beginning balance at Mar. 31, 2023 289,409       $ 24 $ 2 370,814   (36,495) (44,936)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises of vested stock options (in shares)         38,374            
Exercises of vested stock options 259           259        
Vesting of restricted stock units (in shares)         58,084            
Equity awards withheld for tax liability (in shares)         (2,289)            
Equity awards withheld for tax liability (30)           (30)        
Unrealized loss on marketable securities 54               54    
Foreign currency translation 234               234    
Stock-based compensation 5,866           5,866        
Net loss (3,890)                 (3,890)  
Ending balance (in shares) at Jun. 30, 2023         23,624,769 1,965,170          
Ending balance at Jun. 30, 2023 291,902       $ 24 $ 2 376,909   (36,207) (48,826)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Vesting of restricted stock units (in shares)         51,132            
Equity awards withheld for tax liability (in shares)         (242)            
Equity awards withheld for tax liability (3)           (3)        
Shares converted (in shares)         7,142 (7,142)          
Unrealized loss on marketable securities (129)               (129)    
Foreign currency translation (12,760)               (12,760)    
Stock-based compensation 6,107           6,107        
Net loss (5,130)                 (5,130)  
Ending balance (in shares) at Sep. 30, 2023     23,682,801 1,958,028 23,682,801 1,958,028          
Ending balance at Sep. 30, 2023 $ 279,987       $ 24 $ 2 $ 383,013   $ (49,096) $ (53,956)